DK1311272T3 - Hidtil ukendte fremgangsmåder hvor der anvendes cholinesteraseinhibitorer - Google Patents
Hidtil ukendte fremgangsmåder hvor der anvendes cholinesteraseinhibitorerInfo
- Publication number
- DK1311272T3 DK1311272T3 DK01922272T DK01922272T DK1311272T3 DK 1311272 T3 DK1311272 T3 DK 1311272T3 DK 01922272 T DK01922272 T DK 01922272T DK 01922272 T DK01922272 T DK 01922272T DK 1311272 T3 DK1311272 T3 DK 1311272T3
- Authority
- DK
- Denmark
- Prior art keywords
- cholinesterase inhibitors
- new methods
- cholinesterase
- inhibitors
- donepezil
- Prior art date
Links
- 239000000544 cholinesterase inhibitor Substances 0.000 title abstract 2
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 abstract 2
- 208000028698 Cognitive impairment Diseases 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 229960003530 donepezil Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18674400P | 2000-03-03 | 2000-03-03 | |
US19761000P | 2000-04-18 | 2000-04-18 | |
US22078300P | 2000-07-25 | 2000-07-25 | |
US25922601P | 2001-01-03 | 2001-01-03 | |
PCT/US2001/007027 WO2001066114A1 (en) | 2000-03-03 | 2001-03-05 | Novel methods using cholinesterase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1311272T3 true DK1311272T3 (da) | 2007-02-26 |
Family
ID=27497683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01922272T DK1311272T3 (da) | 2000-03-03 | 2001-03-05 | Hidtil ukendte fremgangsmåder hvor der anvendes cholinesteraseinhibitorer |
Country Status (11)
Families Citing this family (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60124730T2 (de) * | 2000-03-03 | 2007-10-04 | Eisai R&D Management Co., Ltd. | Neue methoden unter verwendung von cholinesteraseinhibitoren |
US20060183776A9 (en) * | 2000-03-03 | 2006-08-17 | Eisai Co., Ltd. | Liquid dosage formulations of donepezil |
US20030153598A1 (en) * | 2000-07-25 | 2003-08-14 | Raymond Pratt | Methods for treating Parkinson's disease with cholinesterase inhibitors |
AU2002245692A1 (en) * | 2001-03-15 | 2002-10-03 | David Pharmaceuticals | Methods for restoring cognitive function following systemic stress |
WO2003020289A1 (en) * | 2001-08-30 | 2003-03-13 | Ortho-Mcneil Pharmaceutical, Inc. | Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors |
AU2002340232A1 (en) * | 2001-10-17 | 2003-04-28 | Eisai Co., Ltd. | Methods for treating substance abuse with cholinesterase inhibitors |
EP1468684A4 (en) * | 2002-01-22 | 2008-02-27 | Eisai R&D Man Co Ltd | SIGMA RECEPTOR BINDING MOLECULE WITH INDANO DERIVATIVE |
US20030162770A1 (en) * | 2002-02-22 | 2003-08-28 | Davis Bonnie M. | Use of modulators of nicotinic receptors for treatment of cognitive dysfunction |
AU2003298514A1 (en) * | 2002-05-17 | 2004-05-04 | Eisai Co., Ltd. | Methods and compositions using cholinesterase inhibitors |
US20070053976A1 (en) * | 2002-05-17 | 2007-03-08 | Eisai R & D Management Co., Ltd. | Novel combination of drugs as antidepressant |
US20060129385A1 (en) * | 2002-07-22 | 2006-06-15 | Heller James H | Cholinergic therapy for individuals with learning disabilities |
AU2003287433A1 (en) * | 2002-11-01 | 2004-06-07 | Oregon Health And Science University | Treatment of hyperkinetic movement disorder with donepezil |
AU2004216360B2 (en) * | 2003-02-27 | 2009-09-17 | Eisai R & D Management Co., Ltd. | Pharmaceutical composition for treatment of drug dependence |
EP2617419A1 (en) | 2003-04-24 | 2013-07-24 | Incyte Corporation | Aza spiro alkane derivatives as inhibitors of metallproteases |
IL155666A (en) * | 2003-04-29 | 2013-12-31 | Neurim Pharma 1991 | Insomnia treatment |
US9119846B2 (en) * | 2003-04-29 | 2015-09-01 | Neurim Pharmaceuticals (1991) Ltd. | Method and composition for enhancing cognition in alzheimer's patients |
JP2007502863A (ja) * | 2003-05-23 | 2007-02-15 | コグニション ファーマシューティカルズ エルエルシー | 認知障害の治療および認知改善の方法 |
DE602004014372D1 (de) | 2003-06-17 | 2008-07-24 | Pfizer | N-pyrrolidin-3-yl-amide-derivate als inhibitoren der serotonin- und noradrenalin-wiederaufnahme |
US20070054940A1 (en) * | 2003-09-19 | 2007-03-08 | Eisai Co., Ltd. | Remedy for down's syndrome |
US20050232990A1 (en) * | 2003-12-31 | 2005-10-20 | Garth Boehm | Donepezil formulations |
AU2005208566A1 (en) * | 2004-01-22 | 2005-08-11 | Genaissance Pharmaceuticals, Inc. | APOE genetic markers associated with age of onset of Alzheimer's Disease |
EP1715863B1 (en) * | 2004-01-26 | 2012-05-09 | Cortex Pharmaceuticals, Inc. | Enhancement of ampakine-induced facilitation of synaptic responses by cholinesterase inhibitors |
AU2005210623A1 (en) * | 2004-01-30 | 2005-08-18 | Axonyx, Inc. | Methods for treatment of complications of diabetes |
WO2005089504A2 (en) * | 2004-03-18 | 2005-09-29 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
US20050272722A1 (en) * | 2004-03-18 | 2005-12-08 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
JP2007529555A (ja) * | 2004-03-18 | 2007-10-25 | ザ ブライハム アンド ウイメンズ ホスピタル, インコーポレイテッド | シヌクレイノパチーを治療する方法 |
US20070293539A1 (en) * | 2004-03-18 | 2007-12-20 | Lansbury Peter T | Methods for the treatment of synucleinopathies |
EP1744751A4 (en) * | 2004-03-18 | 2010-03-10 | Brigham & Womens Hospital | TREATMENT OF SYNUCLEINOPATHIES |
TW200533371A (en) * | 2004-04-15 | 2005-10-16 | Dainippon Pharmaceutical Co | Medicament comprising a combination of an acetylcholinesterase inhibitor and a 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivative |
US20060135507A1 (en) * | 2004-08-13 | 2006-06-22 | Osamu Yokoyama | Therapeutic agent for overactive bladder involved in aging |
US7718674B2 (en) * | 2004-09-27 | 2010-05-18 | Bridge Pharma, Inc. | Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine |
US20060079558A1 (en) * | 2004-09-27 | 2006-04-13 | Bridge Pharma. Inc. | R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics |
JP5180816B2 (ja) * | 2005-04-04 | 2013-04-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 神経変性疾患および認知症のためのジヒドロピリジン化合物 |
GB0605544D0 (en) * | 2006-03-20 | 2006-04-26 | Univ Nottingham | Genetic Markers For Alzheimer Disease |
US7858611B2 (en) * | 2006-05-09 | 2010-12-28 | Braincells Inc. | Neurogenesis by modulating angiotensin |
US7910108B2 (en) * | 2006-06-05 | 2011-03-22 | Incyte Corporation | Sheddase inhibitors combined with CD30-binding immunotherapeutics for the treatment of CD30 positive diseases |
CA2655809C (en) * | 2006-07-21 | 2013-10-01 | Bridge Pharma, Inc. | Dermal anesthetic compounds |
US8012994B1 (en) | 2006-09-22 | 2011-09-06 | Sevastyanov Victor V | Method for the treatment of sensorineural hearing loss with donepezil hydrochloride (ARICEPT®) |
CN101573115B (zh) * | 2006-12-01 | 2012-06-06 | 日东电工株式会社 | 抑制含有多奈哌齐的贴剂着色的方法、及降低多奈哌齐类似物的生成量的方法 |
BRPI0719307A2 (pt) * | 2006-12-01 | 2014-02-04 | Nitto Denko Corp | Método para a supressão da descoloração ao longo do tempo da preparação adesiva contendo donepezil. |
JP2010520154A (ja) * | 2007-03-05 | 2010-06-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 神経変性疾患のためのampaレセプターアンタゴニストおよびnmdaレセプターアンタゴニスト |
US20100130537A1 (en) * | 2007-04-26 | 2010-05-27 | Eisai R&D Management Co., Ltd | Cinnamide compounds for dementia |
NZ580801A (en) * | 2007-05-10 | 2012-09-28 | Bristol Myers Squibb Co | Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
WO2009058851A2 (en) * | 2007-10-31 | 2009-05-07 | Alseres Pharmaceuticals, Inc. | Methods for diagnosing and monitoring treatment of lewy body dementia by assessing dopamine transporter level |
US20090156561A1 (en) * | 2007-12-13 | 2009-06-18 | Seed John C | Use of Cholinesterase Inhibitors In Smoking Cessation |
US8232402B2 (en) * | 2008-03-12 | 2012-07-31 | Link Medicine Corporation | Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications |
WO2009128058A1 (en) | 2008-04-18 | 2009-10-22 | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al | Psycho-pharmaceuticals |
US8461389B2 (en) | 2008-04-18 | 2013-06-11 | University College Dublin, National University Of Ireland, Dublin | Psycho-pharmaceuticals |
US20090291127A1 (en) * | 2008-05-21 | 2009-11-26 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
CA2725484A1 (en) * | 2008-05-30 | 2009-12-03 | Eisai R&D Management Co., Ltd. | Percutaneously absorbable preparation |
US20110056863A1 (en) * | 2008-05-30 | 2011-03-10 | Junichi Sekiya | Adhesive preparation containing donepezil, and package of the same |
JP2012504163A (ja) * | 2008-09-30 | 2012-02-16 | テイコク ファーマ ユーエスエー インコーポレーテッド | 経皮持続送達ドネペジル組成物および該組成物を使用する方法 |
MX2011005096A (es) * | 2008-11-13 | 2011-11-18 | Link Medicine Corp | Derivados de azaquinolinona y usos de los mismos. |
US20110060005A1 (en) * | 2008-11-13 | 2011-03-10 | Link Medicine Corporation | Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
US20100331363A1 (en) * | 2008-11-13 | 2010-12-30 | Link Medicine Corporation | Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
CN102395371A (zh) * | 2009-04-13 | 2012-03-28 | 施万制药 | 用于治疗认知障碍的5-ht4受体促效剂化合物 |
US20100178307A1 (en) * | 2010-01-13 | 2010-07-15 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
AU2011215870B2 (en) | 2010-02-09 | 2016-01-28 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
EP2366378A1 (en) | 2010-03-01 | 2011-09-21 | Dexcel Pharma Technologies Ltd. | Sustained-release donepezil formulations |
WO2011127235A1 (en) | 2010-04-07 | 2011-10-13 | Eisai Inc. | Combination therapy for the treatment of dementia |
GR1007368B (el) | 2010-05-27 | 2011-08-02 | Alapis Α.Β.Ε.Ε., | Ποσιμα φαρμακευτικα διαλυματα για τη θεραπεια των συμπτωματων της ανοιας |
WO2011151359A1 (en) | 2010-06-02 | 2011-12-08 | Noscira, S.A. | Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative |
US8980924B2 (en) | 2010-11-24 | 2015-03-17 | The Trustees Of Columbia University In The City Of New York | Non-retinoid RBP4 antagonist for treatment of age-related macular degeneration and stargardt disease |
US20120225922A1 (en) | 2011-03-04 | 2012-09-06 | Qr Pharma | Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration |
WO2013109543A1 (en) * | 2012-01-20 | 2013-07-25 | The Board Of Trustees Of The Leland Stanford Junior University | Small molecule cmklr1 antagonists in demyelinating disease |
US9333202B2 (en) | 2012-05-01 | 2016-05-10 | The Trustees Of Columbia University In The City Of New York | Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease |
WO2014078568A1 (en) * | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
US9944644B2 (en) | 2013-03-14 | 2018-04-17 | The Trustees Of Columbia University In The City Of New York | Octahydropyrrolopyrroles their preparation and use |
ES2705247T3 (es) | 2013-03-14 | 2019-03-22 | Univ Columbia | 4-fenilpiperidinas, su preparación y uso |
WO2014151959A1 (en) | 2013-03-14 | 2014-09-25 | The Trustees Of Columbia University In The City Of New York | N-alkyl-2-phenoxyethanamines, their preparation and use |
US9637450B2 (en) | 2013-03-14 | 2017-05-02 | The Trustees Of Columbia University In The City Of New York | Octahydrocyclopentapyrroles, their preparation and use |
EP3827820A1 (en) | 2013-03-15 | 2021-06-02 | The Johns Hopkins University | Brivaracetam for improving cognitive function |
CN105142623A (zh) | 2013-03-15 | 2015-12-09 | 艾吉因生物股份有限公司 | 用于改善认知功能的方法和组合物 |
US9359315B2 (en) * | 2013-09-10 | 2016-06-07 | Arrien Pharmaceuticals Llc | Substituted 2,3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis |
CN111393434B (zh) | 2014-04-30 | 2022-11-04 | 哥伦比亚大学董事会 | 取代的4-苯基哌啶及其制备和用途 |
AR103297A1 (es) | 2014-12-30 | 2017-05-03 | Forma Therapeutics Inc | Pirrolo y pirazolopirimidinas como inhibidores de la proteasa 7 específica de ubiquitina |
MA41291A (fr) | 2014-12-30 | 2017-11-07 | Forma Therapeutics Inc | Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer |
US9938300B2 (en) | 2015-02-05 | 2018-04-10 | Forma Therapeutics, Inc. | Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors |
US9840491B2 (en) | 2015-02-05 | 2017-12-12 | Forma Therapeutics, Inc. | Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors |
JP2018504431A (ja) | 2015-02-05 | 2018-02-15 | フォーマ セラピューティクス,インコーポレイテッド | ユビキチン特異的プロテアーゼ7阻害物質としてのチエノピリミジノン |
CN112843005B (zh) | 2015-05-22 | 2023-02-21 | 艾吉因生物股份有限公司 | 左乙拉西坦的延时释放药物组合物 |
US20180228771A1 (en) * | 2015-08-14 | 2018-08-16 | Qr Pharma | Methods of treatment or prevention of acute brain or nerve injuries |
EP3654957A4 (en) | 2017-05-24 | 2021-06-23 | Annovis Bio, Inc. | PREVENTION OR TREATMENT OF DISEASE CONDITIONS DUE TO METAL DIS-HOMEOSTASIS BY ADMINISTERING POSIPHES TO HEALTHY OR SICK PEOPLE |
JP2021501210A (ja) | 2017-10-30 | 2021-01-14 | モントリオール ハート インスティテュート | 血漿コレステロールの上昇を処置する方法 |
JP2022541021A (ja) * | 2019-07-16 | 2022-09-21 | ラッシュ・ユニバーシティ・メディカル・センター | 神経変性障害を治療するためのベンゾエート含有組成物の使用 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL74497A (en) * | 1985-03-05 | 1990-02-09 | Proterra Ag | Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives |
US4826843A (en) * | 1985-07-08 | 1989-05-02 | Bristol-Myers | Cerebral function enhancing diazinylpiperidine derivatives |
FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
JP2777159B2 (ja) * | 1988-12-22 | 1998-07-16 | エーザイ株式会社 | 環状アミン誘導体を含有する医薬 |
JP3075566B2 (ja) | 1990-05-15 | 2000-08-14 | エーザイ株式会社 | 光学活性インダノン誘導体 |
JP2965675B2 (ja) | 1990-11-21 | 1999-10-18 | エーザイ株式会社 | (―)―1―ベンジル―4―〔(5,6―ジメトキシ―1―インダノン)―2―イル〕メチルピペリジンの製造方法 |
US5668117A (en) * | 1991-02-22 | 1997-09-16 | Shapiro; Howard K. | Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments |
CA2113115A1 (en) * | 1991-07-29 | 1993-02-18 | Vlad E. Gregor | Quinazoline derivatives as acetylcholinesterase inhibitors |
SE9103752D0 (sv) * | 1991-12-18 | 1991-12-18 | Astra Ab | New compounds |
TW513409B (en) | 1996-06-07 | 2002-12-11 | Eisai Co Ltd | Polymorphs of donepezil hydrochloride |
AU1153097A (en) | 1996-06-07 | 1998-01-05 | Eisai Co. Ltd. | Stable polymorphs of donepezil (1-benzyl-4-{(5,6-dimethoxy-1-indanon)-2-yl}methylpiperidine ) hydrochloride and process for production |
WO1997046527A1 (en) | 1996-06-07 | 1997-12-11 | Eisai Co., Ltd. | Polymorphs of donepezil hydrochloride and process for production |
US5965571A (en) * | 1996-08-22 | 1999-10-12 | New York University | Cholinesterase inhibitors for treatment of Parkinson's disease |
AU743609B2 (en) | 1997-03-03 | 2002-01-31 | Eisai Co. Ltd. | Use of cholinesterase inhibitors to treat disorders of attention |
CA2304505A1 (en) * | 1997-09-24 | 1999-04-01 | Nova Molecular, Inc. | Methods for increasing apoe levels for the treatment of neurodegenerative disease |
ES2218869T3 (es) | 1997-12-05 | 2004-11-16 | Eisai Co., Ltd. | Cristales polimorficos de donepezil y un proceso para produccion de dichos cristales. |
WO1999036405A1 (en) | 1998-01-16 | 1999-07-22 | Eisai Co., Ltd. | Process for production of donepezil derivative |
US6193993B1 (en) | 1998-03-03 | 2001-02-27 | Eisai Co., Ltd. | Suppository containing an antidementia medicament |
US6576677B1 (en) | 1998-08-28 | 2003-06-10 | Eisai Co., Ltd. | Medicinal compositions with relieved bitterness |
IT1304904B1 (it) | 1998-09-11 | 2001-04-05 | Eisai Co Ltd | Derivati anticolinesterasici per il trattamento delle sindromidolorose funzionali e/o organiche |
WO2000059544A1 (fr) | 1999-03-31 | 2000-10-12 | Eisai Co., Ltd. | Compositions stabilisees contenant des medicaments nootropes |
DE60124730T2 (de) * | 2000-03-03 | 2007-10-04 | Eisai R&D Management Co., Ltd. | Neue methoden unter verwendung von cholinesteraseinhibitoren |
US20060183776A9 (en) * | 2000-03-03 | 2006-08-17 | Eisai Co., Ltd. | Liquid dosage formulations of donepezil |
US20030153598A1 (en) * | 2000-07-25 | 2003-08-14 | Raymond Pratt | Methods for treating Parkinson's disease with cholinesterase inhibitors |
AU2001239052A1 (en) | 2000-03-06 | 2001-09-17 | Immune Network Ltd. | Compositions for prevention and treatment of dementia |
US20010036949A1 (en) | 2000-05-09 | 2001-11-01 | Coe Jotham Wadsworth | Pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal |
WO2003024456A1 (en) | 2001-09-20 | 2003-03-27 | Eisai Co., Ltd. | Methods for treating and preventing migraines |
WO2003024450A1 (en) | 2001-09-20 | 2003-03-27 | Eisai Co., Ltd. | Methods for treating prion diseases |
AU2002340232A1 (en) | 2001-10-17 | 2003-04-28 | Eisai Co., Ltd. | Methods for treating substance abuse with cholinesterase inhibitors |
WO2003092606A2 (en) | 2002-05-01 | 2003-11-13 | Eisai Co., Ltd. | Cholinesterase inhibitors to prevent injuries caused by chemicals |
AU2003298514A1 (en) | 2002-05-17 | 2004-05-04 | Eisai Co., Ltd. | Methods and compositions using cholinesterase inhibitors |
AU2003287433A1 (en) * | 2002-11-01 | 2004-06-07 | Oregon Health And Science University | Treatment of hyperkinetic movement disorder with donepezil |
-
2001
- 2001-03-05 DE DE60124730T patent/DE60124730T2/de not_active Expired - Lifetime
- 2001-03-05 JP JP2001564766A patent/JP2003525903A/ja active Pending
- 2001-03-05 EP EP09011085A patent/EP2140868A1/en not_active Withdrawn
- 2001-03-05 ES ES01922272T patent/ES2275670T3/es not_active Expired - Lifetime
- 2001-03-05 AU AU2001249091A patent/AU2001249091A1/en not_active Abandoned
- 2001-03-05 EP EP09011084A patent/EP2133078A1/en not_active Withdrawn
- 2001-03-05 EP EP01922272A patent/EP1311272B1/en not_active Expired - Lifetime
- 2001-03-05 DK DK01922272T patent/DK1311272T3/da active
- 2001-03-05 WO PCT/US2001/007027 patent/WO2001066114A1/en active IP Right Grant
- 2001-03-05 EP EP09011051A patent/EP2138177A1/en not_active Withdrawn
- 2001-03-05 AT AT01922272T patent/ATE345803T1/de active
- 2001-03-05 EP EP09011050A patent/EP2130538A1/en not_active Withdrawn
- 2001-03-05 PT PT01922272T patent/PT1311272E/pt unknown
- 2001-07-06 US US09/899,028 patent/US20020035128A1/en not_active Abandoned
- 2001-09-04 US US09/947,087 patent/US6482838B2/en not_active Expired - Fee Related
- 2001-09-04 US US09/947,086 patent/US6458807B1/en not_active Expired - Lifetime
-
2002
- 2002-01-25 US US10/054,931 patent/US6576646B1/en not_active Expired - Fee Related
- 2002-09-03 US US10/232,406 patent/US6689795B2/en not_active Expired - Fee Related
-
2003
- 2003-12-11 US US10/732,349 patent/US7563808B2/en not_active Expired - Fee Related
-
2005
- 2005-07-15 US US11/181,855 patent/US20050250812A1/en not_active Abandoned
-
2007
- 2007-01-29 CY CY20071100121T patent/CY1107997T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP2138177A1 (en) | 2009-12-30 |
US6482838B2 (en) | 2002-11-19 |
CY1107997T1 (el) | 2013-09-04 |
EP2133078A1 (en) | 2009-12-16 |
WO2001066114A1 (en) | 2001-09-13 |
AU2001249091A1 (en) | 2001-09-17 |
ES2275670T3 (es) | 2007-06-16 |
EP1311272A4 (en) | 2003-05-21 |
US6458807B1 (en) | 2002-10-01 |
US20050250812A1 (en) | 2005-11-10 |
US20030040532A1 (en) | 2003-02-27 |
EP1311272A1 (en) | 2003-05-21 |
US20020035129A1 (en) | 2002-03-21 |
US20020040038A1 (en) | 2002-04-04 |
EP2130538A1 (en) | 2009-12-09 |
US20040122051A1 (en) | 2004-06-24 |
US6576646B1 (en) | 2003-06-10 |
ATE345803T1 (de) | 2006-12-15 |
DE60124730D1 (de) | 2007-01-04 |
EP2140868A1 (en) | 2010-01-06 |
PT1311272E (pt) | 2007-02-28 |
US6689795B2 (en) | 2004-02-10 |
US20020035128A1 (en) | 2002-03-21 |
DE60124730T2 (de) | 2007-10-04 |
US7563808B2 (en) | 2009-07-21 |
JP2003525903A (ja) | 2003-09-02 |
EP1311272B1 (en) | 2006-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1311272T3 (da) | Hidtil ukendte fremgangsmåder hvor der anvendes cholinesteraseinhibitorer | |
ATE387444T1 (de) | Substituierte pyrroline als kinase inhibitoren | |
ATE520674T1 (de) | Natriumkanalblocker | |
ATE409035T1 (de) | Substituierte pyrroline als kinase inhibitoren | |
UY26820A1 (es) | Derivados de ciclopentil-glutaramida como inhibidores de endopeptidasa neutra | |
ATE510534T1 (de) | Naltrexonhydrochlorid-zusammensetzungen | |
HK1119699A1 (en) | Pyridopyrimidinone inhibitors of pi3kalpha | |
HK1099235A1 (en) | Phosphonate analogs of hiv integrase inhibitor compounds hiv | |
SE0203713D0 (sv) | Novel compounds | |
DK1362047T3 (da) | Indazolylsubstituerede pyrrolinforbindelser som kinaseinhibitorer | |
NO20052976L (no) | Fosfodiesterase-4-inhibitorer. | |
MX2009006864A (es) | Inhibidores novedosos de c jun-n-terminal cinasas. | |
NO20062062L (no) | Procsesser for preparering av forskjellige former for (S)-(+)-clopidogrel bisulfat | |
DE602004031372D1 (de) | Nachweis von staphylococcus | |
TW200605871A (en) | Carboxamido opioid compounds | |
DK1421075T3 (da) | Piperidinderivater, der er nyttige som CCR5-antagonister til behandling af HIV | |
HN2008001934A (es) | 18-metil-19-nor-androst-4-en-17,17-espiroesteres (18-metil-19-nor-20-espirox-4-en-3-onas), asi como preparaciones farmaceuticas que los contienen. | |
ZA200404752B (en) | 6-aminomorphinane derivatives method for the production and use thereof | |
NO20025405D0 (no) | Modulatorer for TNF-alfa-signalisering | |
BRPI0409376A (pt) | derivados de indeno como agentes farmacêuticos | |
EA200100930A1 (ru) | Способ лечения хозл | |
DK1206452T3 (da) | Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser | |
ATE481408T1 (de) | Reinigung von beta-lactam-verbindungen | |
ATE412634T1 (de) | Piperazinderivate von alkyloxindolen | |
NO20051468L (no) | Behandling av ikke-allergisk rhinitt med selektive fosfodiesterase-4-inhibitorer |